Ontology highlight
ABSTRACT: Background
Psoriasis is associated with several comorbidities and patients with psoriasis are more often obese than individuals without psoriasis. The excess disease burden is important to consider in choice of and response to treatment at the individual level.Objective
To investigate whether patient characteristics differ across biologics for patients initiating biologic therapy and for patients still on biologic therapy after 1 year. Also, to quantify and compare the use of topical therapy among patients still on biologic therapy after 1 year.Methods
This nationwide cohort study compared characteristics of patients prescribed adalimumab, etanercept, infliximab, secukinumab or ustekinumab for treatment of psoriasis by using data from the Danish registries.Resul
SUBMITTER: Schwarz CW
PROVIDER: S-EPMC11361497 | biostudies-literature | 2024 Apr
REPOSITORIES: biostudies-literature